Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.

Welcome to Part II of our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

Read our roundtable discussion about a pilot program in the US for novel excipients featuring experts from IPEC-Americas.

We find out more about the video game that won FDA approval as a treatment for children with ADHD

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.

After other defendants in the case settle, Teva is left to face the music in New York alone.

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

Can ten23 health really make a difference to the planet while fully supporting its biopharma customers? We find out.

AppliedVR gets FDA OK to market virtual reality system for chronic pain.

How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?